MoneyWorks4Me

Granules India’s Q3 consolidated net rises by 42%

25 Jan 2012 Evaluate

Granules India has reported results for its third quarter ended December 31, 2011.

The company’s net profit declined by 4.94%, to Rs 5.96 crore in the third quarter ended December 31, 2011 compared with Rs 6.27 crore in the year-ago period. Net sales grew 41.20% to Rs 155.56 crore in the quarter under review as compared with Rs 110.17 crore in the same quarter last year.

The company’s consolidated net profit increased 41.92%, to Rs 7.99 crore in the third quarter ended December 31, 2011 compared with Rs 5.63 crore in the year-ago period. Net sales grew 45% to Rs 185.72 crore in the quarter under review as compared with Rs 128 crore in the same quarter last year. 

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..